Mahamadzhonov Islombek Abdurasul Ugli (1)
General Background: Infectious mononucleosis (IM) caused by Epstein–Barr virus (EBV) is a common childhood infection that can lead to complications when diagnosis and treatment are delayed. Specific Background: Pediatric IM often shows atypical symptoms resembling other viral illnesses, causing frequent diagnostic delays. Knowledge Gap: There is limited evidence on how such delays affect disease severity and recovery in children. Aims: This study examined the relationship between diagnostic and treatment delays and clinical outcomes in pediatric IM. Results: Children diagnosed more than 10 days after symptom onset had longer recovery, more hepatic and lymphoid complications, and higher inflammation than those diagnosed early. Novelty: The study reveals a clear link between diagnostic delay and poorer outcomes in pediatric EBV infections. Implications: Early diagnosis and standardized management are essential to prevent complications and improve recovery in infected children. Highlight :
Delay in diagnosis leads to prolonged illness and higher complication rates in children.
Early diagnosis and treatment improve recovery and reduce systemic inflammation.
Highlights the need for standardized pediatric diagnostic and treatment guidelines
Keywords : Infectious mononucleosis, Epstein-Barr virus, diagnostic delay, pediatric infection, early treatment
P. Lennon, M. Crotty, and J. E. Fenton, “Infectious Mononucleosis,” BMJ, vol. 350, p. h1825, 2015. Available: [https://doi.org/10.1136/bmj.h1825](https://doi.org/10.1136/bmj.h1825)
R. Pricoco, P. Meidel, T. Hofberger, H. Zietemann, Y. Mueller, K. Wiehler, et al., “One-Year Follow-Up of Young People with ME/CFS Following Infectious Mononucleosis by Epstein–Barr Virus,” Frontiers in Pediatrics, vol. 11, p. 1266738, 2024. Available: [https://doi.org/10.3389/fped.2024.1266738](https://doi.org/10.3389/fped.2024.1266738)
T. Shi, L. Huang, L. Luo, Q. Yu, and J. Tian, “Diagnostic Value of Serological and Molecular Biological Tests for Infectious Mononucleosis by EBV in Different Age Stages and Course of the Disease,” Journal of Medical Virology, vol. 93, no. 6, pp. 3824–3834, 2021. Available: [https://doi.org/10.1002/jmv.26656](https://doi.org/10.1002/jmv.26656)
R. Zhang, Z. Mao, C. Xu, W. Wang, J. S. W. Kwong, M. Xu, et al., “Association Between Antibiotic Exposure and the Risk of Rash in Children with Infectious Mononucleosis: A Multicenter, Retrospective Cohort Study,” Antimicrobial Agents and Chemotherapy, vol. 67, no. 6, p. e00249-23, 2023. Available: [https://doi.org/10.1128/aac.00249-23](https://doi.org/10.1128/aac.00249-23)
L. Cai, Y. Xing, Y. Xia, Z. Zhang, Z. Luo, Y. Tang, et al., “Comparative Study of Biomarkers for the Early Identification of Epstein–Barr Virus-Associated Hemophagocytic Lymphohistiocytosis in Infectious Mononucleosis,” BMC Infectious Diseases, vol. 23, no. 1, p. 728, 2023. Available: [https://doi.org/10.1186/s12879-023-08476-1](https://doi.org/10.1186/s12879-023-08476-1)
T. Shi, J. Li, Y. Miao, L. Huang, and J. Tian, “Adenosine Deaminase as a Marker for the Severity of Infectious Mononucleosis Secondary to EBV in Children,” BMC Infectious Diseases, vol. 22, no. 1, p. 164, 2022. Available: [https://doi.org/10.1186/s12879-022-07163-1](https://doi.org/10.1186/s12879-022-07163-1)
M. Rutkowska and M. Pokorska-Spiewak, “The Influence of Steroid Therapy of Complications of Infectious Mononucleosis on the Course of Epstein–Barr Virus Hepatitis,” Clinical and Experimental Hepatology, vol. 9, no. 4, pp. 375–385, 2023. Available: [https://doi.org/10.5114/ceh.2023.132657](https://doi.org/10.5114/ceh.2023.132657)
J. C. Niederman, R. W. McCollum, G. Henle, and W. Henle, “Infectious Mononucleosis: Clinical Manifestations in Relation to EB Virus Antibodies,” JAMA, vol. 203, no. 3, pp. 205–209, 1968. Available: [https://doi.org/10.1001/jama.1968.03140030019005](https://doi.org/10.1001/jama.1968.03140030019005)
T. Azzi, A. Lunemann, A. Murer, S. Ueda, V. Beziat, K. J. Malmberg, et al., “Role for Early-Differentiated Natural Killer Cells in Infectious Mononucleosis,” Blood, vol. 124, no. 16, pp. 2533–2543, 2014. Available: [https://doi.org/10.1182/blood-2014-04-571232](https://doi.org/10.1182/blood-2014-04-571232)
M. Khundadze, L. Khurtsia, N. Shulaia, and G. Kandelaki, “When Histiocytosis Masquerades as Mononucleosis: A Case Report,” Cureus, vol. 16, no. 9, 2024. Available: [https://doi.org/10.7759/cureus.70718](https://doi.org/10.7759/cureus.70718)
B. Wistinghausen, T. G. Gross, and C. Bollard, “Post-Transplant Lymphoproliferative Disease in Pediatric Solid Organ Transplant Recipients,” Pediatric Hematology and Oncology, vol. 30, no. 6, pp. 520–531, 2013. Available: [https://doi.org/10.3109/08880018.2013.794058](https://doi.org/10.3109/08880018.2013.794058)
W. J. Liu, Q. J. Yi, Q. L. Guo, H. Y. Chen, and K. Z. Wang, “Proteomic Analysis of the Diagnostic Biomarker for Childhood Infectious Mononucleosis,” African Journal of Pharmacy and Pharmacology, vol. 7, no. 9, pp. 495–502, 2013. Available: [https://doi.org/10.5897/AJPP12.1140](https://doi.org/10.5897/AJPP12.1140)
P. Lennon, “Management of Infectious Mononucleosis,” Ph.D. dissertation, University of Limerick, Limerick, Ireland, 2018.
K. F. Macsween, T. Haque, and I. Johannessen, “Human Herpesviruses: Infectious Mononucleosis and Other Non-Malignant Diseases,” in Viral Infections of Humans: Epidemiology and Control, 6th ed., New York, NY: Springer US, 2022, pp. 1–64. Available: [https://doi.org/10.1007/978-1-0716-2308-2_1](https://doi.org/10.1007/978-1-0716-2308-2_1)
B. Zhang, I. K. Choi, J. Panaampon, and Z. Wang, “Does Delayed EBV Infection Contribute to Rising Childhood Cancers?,” Trends in Immunology, vol. 43, no. 12, pp. 956–958, 2022. Available: [https://doi.org/10.1016/j.it.2022.09.003](https://doi.org/10.1016/j.it.2022.09.003)